Serif Senturk

15PUBLICATIONS
30CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 24, 2026
Correction: Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancer.

|Oct 09, 2025
Modeling hepatic fibrosis in TP53 knockout iPSC-derived human liver organoids.

Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan

|May 25, 2025
Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancer.

|Apr 17, 2025
The G protein-coupled receptor GPR89A is a novel potential therapeutic target to overcome cisplatin resistance in NSCLC Calu1 cells.

Hale Guler Kara, Eda Dogan, Vildan Bozok

|Apr 03, 2025
Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma.

Ece Cakiroglu, Sude Eris, Ozden Oz

|Mar 14, 2025
Escape from TGF-β-induced senescence promotes aggressive hallmarks in epithelial hepatocellular carcinoma cells.

Minenur Kalyoncu, Dilara Demirci, Sude Eris

Pageof 3

Frequent Collaborators

6 joint publications

Gökhan Karakülah

4 joint publications

Sude Eris

2 joint publications

Dilara Demirci

2 joint publications

Nazife Ege Gulfirat